McKenzie Banks
Family · Atlanta, GANPI 1730776410
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,916 and has fallen 98.7% since, to $24 in 2024.
Across 214 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$531
- AbbVie$518
- Novartis$344
- Eisai Inc.$165
- SK Life Science, Inc.$148
- Kyowa Kirin, Inc.$148
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 29 | $531 |
| AbbVie | 35 | $518 |
| Novartis | 31 | $344 |
| Eisai Inc. | 10 | $165 |
| SK Life Science, Inc. | 8 | $148 |
| Kyowa Kirin, Inc. | 9 | $148 |
| Alnylam Pharmaceuticals Inc. | 7 | $140 |
| Sanofi | 6 | $123 |
| Sunovion Pharmaceuticals Inc. | 7 | $115 |
| Teva Pharmaceuticals USA, Inc. | 6 | $114 |
| Greenwich Biosciences, Inc. | 5 | $102 |
| Acorda Therapeutics, Inc | 6 | $97 |
| Lundbeck LLC | 5 | $95 |
| UCB, Inc. | 4 | $85 |
| Amneal Pharmaceuticals LLC | 4 | $82 |
| Lilly USA, LLC | 4 | $78 |
| Biohaven Pharmaceuticals, Inc. | 4 | $77 |
| Argenx US, Inc. | 3 | $60 |
| Pfizer | 3 | $53 |
| Johnson & Johnson | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $40 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 2 | $37 |
| Neurelis, Inc. | 2 | $36 |
| AstraZeneca | 2 | $33 |
| Genentech USA, Inc. | 2 | $31 |
| Avion Pharmaceuticals | 2 | $30 |
| Adamas Pharmaceuticals, Inc. | 2 | $30 |
| Boston Scientific | 1 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| MDD US Operations, LLC | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Harmony Biosciences LLC | 1 | $15 |
| Merck | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$3,588 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Other family in Atlanta
- Stacey TatroeAtlanta$38K
- Brandy HughesAtlanta$29K
- Cecile MartinAtlanta$23K
- Terri CowanAtlanta$21K
- Brandi Pinckney-GreeneAtlanta$18K
- Michelle SarievAtlanta$18K
- Christopher VreelandAtlanta$17K
- Angelica MillerAtlanta$15K
- Andrea Jefferson SaboorAtlanta$14K
- Allie McAllisterMarietta$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.